Sverige - svenska - Läkemedelsverket (Medical Products Agency)

paranova läkemedel ab - allergen, husdammskvalster dermatophagoides farinae; allergen, husdammskvalster dermatophagoides pteronyssinus - frystorkad tablett - 12 sq-hdm - allergen, husdammskvalster dermatophagoides farinae 6 sq-hdm aktiv substans; allergen, husdammskvalster dermatophagoides pteronyssinus 6 sq-hdm aktiv substans; mannitol hjälpämne

Europeiska unionen - svenska - EMA (European Medicines Agency)

recordati rare diseases - osilodrostat fosfat - cushing syndrom - kortikosteroider för systemisk användning - isturisa är indicerat för behandling av endogena cushings syndrom hos vuxna.

Sverige - svenska - Läkemedelsverket (Medical Products Agency)

medartuum ab - allergen, husdammskvalster dermatophagoides farinae; allergen, husdammskvalster dermatophagoides pteronyssinus - frystorkad sublingual tablett - 12 sq-hdm - allergen, husdammskvalster dermatophagoides farinae 6 sq-hdm aktiv substans; mannitol hjälpämne; allergen, husdammskvalster dermatophagoides pteronyssinus 6 sq-hdm aktiv substans

Europeiska unionen - svenska - EMA (European Medicines Agency)

sanofi pasteur - influenza a virus subtype h1n1 haemagglutinin, recombinant, influenza a virus subtype h3n2 haemagglutinin, recombinant, influenza b virus victoria lineage haemagglutinin, recombinant, influenza b virus yamagata lineage haemagglutinin, recombinant - influensa, människa - vacciner - supemtek is indicated for active immunization for the prevention of influenza disease in adults. supemtek should be used in accordance with official recommendations.

Europeiska unionen - svenska - EMA (European Medicines Agency)

daiichi sankyo europe gmbh - pexidartinib - giant cell tumor of tendon sheath; synovitis, pigmented villonodular - antineoplastiska medel - treatment of tenosynovial giant cell tumour.

Sverige - svenska - Läkemedelsverket (Medical Products Agency)

abacus medicine a/s - allergen, husdammskvalster dermatophagoides farinae; allergen, husdammskvalster dermatophagoides pteronyssinus - frystorkad tablett - 12 sq-hdm - allergen, husdammskvalster dermatophagoides pteronyssinus 6 sq-hdm aktiv substans; mannitol hjälpämne; allergen, husdammskvalster dermatophagoides farinae 6 sq-hdm aktiv substans

Europeiska unionen - svenska - EMA (European Medicines Agency)

rhythm pharmaceuticals netherlands b.v. - setmelanotide - fetma - antiobesity preparat, exkl. kost produkter - imcivree is indicated for the treatment of obesity and the control of hunger associated with genetically confirmed bardet biedl syndrome (bbs), loss-of-function biallelic pro-opiomelanocortin (pomc), including pcsk1, deficiency or biallelic leptin receptor (lepr) deficiency in adults and children 6 years of age and above.

Europeiska unionen - svenska - EMA (European Medicines Agency)

roche registration gmbh  - casirivimab, imdevimab - covid-19 virus infection - immunförsvaret sera och immunglobuliner, - ronapreve is indicated for:treatment of covid-19 in adults and adolescents aged 12 years and older weighing at least 40 kg who do not require supplemental oxygen and who are at increased risk of progressing to severe covid-19 (see section 4. prevention of covid-19 in adults and adolescents aged 12 years and older weighing at least 40 kg (see section 4. the use of ronapreve should take into account information on the activity of ronapreve against viral variants of concern. se avsnitt 4. 4 och 5.

Sverige - svenska - Läkemedelsverket (Medical Products Agency)

orifarm ab - allergen, husdammskvalster dermatophagoides farinae; allergen, husdammskvalster dermatophagoides pteronyssinus - frystorkad tablett - 12 sq-hdm - allergen, husdammskvalster dermatophagoides farinae 6 sq-hdm aktiv substans; allergen, husdammskvalster dermatophagoides pteronyssinus 6 sq-hdm aktiv substans; mannitol hjälpämne

Europeiska unionen - svenska - EMA (European Medicines Agency)

sanofi b.v. - olipudase alfa - acid sphingomyelinase deficiency (asmd) type a/b or type b - andra matsmältningsorgan och ämnesomsättning produkter, - xenpozyme is indicated as an enzyme replacement therapy for the treatment of non-central nervous system (cns) manifestations of acid sphingomyelinase deficiency (asmd) in paediatric and adult patients with type a/b or type b.